US Broker Ratings

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.46% Potential Upside and Robust Growth Prospects

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specializes in addressing critical medical needs through innovative treatments for chronic and life-threatening diseases. As of its latest..

Legend Biotech Corporation (LEGN) Stock Analysis: A 275% Upside Potential Amid Strong Analyst Support

Legend Biotech Corporation (NASDAQ: LEGN) is a promising player in the biotechnology sector, focusing on innovative cell therapies for treating cancer. With a market capitalization of $3.16 billion, the company’s..

GSK plc (GSK) Stock Analysis: Navigating a 60.23 USD Peak Amidst Potential Downside Risk

GSK plc (NYSE: GSK), a formidable player in the healthcare sector, has been making waves with its robust portfolio of vaccines and specialty medicines. With a market capitalization of approximately..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 29.81% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing prospect. With a market capitalization of $6.37 billion, this Massachusetts-based company is a notable player..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 22.96% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the rapidly evolving field of precision oncology. By offering cutting-edge blood and tissue tests, Guardant Health aims to..

Grifols, S.A. (GRFS) Investor Outlook: Capturing a 19.61% Potential Upside Amid Growth and Innovation

Grifols, S.A. (GRFS), a renowned name in the healthcare sector, stands out as a key player in the Drug Manufacturers – General industry. With its headquarters in Barcelona, Spain, the..

Labcorp Holdings Inc. (LH) Stock Analysis: Potential Upside with Strong Buy Ratings

Investors looking to delve into the healthcare sector should take note of Labcorp Holdings Inc. (NYSE: LH), a leading player in the Diagnostics & Research industry. With a market capitalization..

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Examining a 31% Potential Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a market capitalization of $10.06 billion. Headquartered in Dublin, Ireland, Jazz specializes..

The Ensign Group, Inc. (ENSG) Stock Analysis: Evaluating a 11.43% Potential Upside

The Ensign Group, Inc. (ENSG), a key player in the healthcare sector, has recently captured the attention of investors with its impressive market cap of $11.49 billion and an enticing..

BioMarin Pharmaceutical Inc. (BMRN)

⚠️ No article content returned.

..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 10.84% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector, stands out in the medical instruments and supplies industry with a market capitalization of $16.32 billion. Headquartered..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 49.94% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is an intriguing player in the Healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $6.87 billion, the company operates a..

Regencell Bioscience Holdings (RGC) Investor Outlook: A Unique Opportunity in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving a niche in the healthcare market through its innovative approach to Traditional Chinese Medicine (TCM). Headquartered in Causeway Bay, Hong Kong, this..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling 14.55% Potential Upside in the Booming Biotechnology Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology giant specializing in oncology, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With a robust market capitalization of $39.16..

The Cigna Group (CI) Stock Analysis: Unpacking a 12.67% Potential Upside

Investors seeking opportunities in the healthcare sector may find The Cigna Group (NYSE: CI) particularly compelling, given its robust market position and optimistic analyst outlook. With a market capitalization of..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Examining the 16.39% Potential Upside for Savvy Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $51.57 billion, the company..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 14.42% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare industry, specifically within the healthcare plans segment. With a substantial market capitalization of $76.33 billion, Elevance Health..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 35.75% Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, currently offers a compelling investment opportunity with a noteworthy potential upside of 35.75%. As the company navigates..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a 2.17% Dividend Yield and High Analyst Confidence

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare industry, continues to capture investor attention with its robust market presence and diverse product offerings. With a market capitalization of..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a key player in the animal health industry, with a market capitalization of $12.52 billion. As a prominent figure in the healthcare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds